Detalhe da pesquisa
1.
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD.
Blood
; 122(25): 4111-8, 2013 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24152907
2.
Plerixafor added to chemotherapy plus G-CSF is safe and allows adequate PBSC collection in predicted poor mobilizer patients with multiple myeloma or lymphoma.
Biol Blood Marrow Transplant
; 18(2): 241-9, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21791194
3.
Evaluation of serological response to anti-SARS-CoV-2 mRNA vaccination in hematological patients.
Front Immunol
; 13: 892331, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36003404
4.
Thrombin Assessment on Nanostructured Label-Free Aptamer-Based Sensors: A Mapping Investigation via Surface-Enhanced Raman Spectroscopy.
Biomed Res Int
; 2018: 5293672, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29750159
5.
Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score.
Bone Marrow Transplant
; 53(4): 461-473, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29330395
6.
Expression of some ATP-binding cassette transporters in acute myeloid leukemia.
Hematol Rep
; 9(4): 7406, 2017 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29333226